| Literature DB >> 36065883 |
Changkeun Kim1,2, Kyung-Won Hong3, Da-Hyun Park3, Sukyung Chun1, Sooyeon Oh1, Youngji Park1, KyongChol Kim4, Sang-Woon Choi1,5, Heejin Jo1.
Abstract
Eight Constitution Medicine (ECM), a ramification of traditional Korean medicine, has categorized people into eight constitutions. The main criteria of classification are inherited differences or predominance in the functions of organs, such as the liver or lung, diagnosed through ECM-specific pulse patterns. This study investigated the association between single nucleotide polymorphism (SNP) genotypes and ECM phenotypes and explored candidate genetic makeups responsible for each constitution using a genome-wide association study (GWAS). Sixty-three healthy volunteers, who were either categorized as the Hepatonia (HEP, n = 32) or Pulmotonia (PUL, n = 31) constitution, were enrolled. HEP and PUL are two contrasting ECM types representing the dominant liver and lung phenotypes, respectively. SNPs were analyzed from the oral mucosa DNA using a commercially available microarray chip that can identify 820,000 SNPs. We conducted GWAS using logistic regression analysis and additive mode genotypes and constructed phylogenetic trees using the SNPhylo program with 8 SNPs specific for the liver phenotype and 15 SNPs for the lung phenotype. Although genome-wide significant SNPs were not found, the phylogenetic tree showed a clear difference between the two constitutions. This is the first observation suggesting genetic involvement in the ECM and can be extended to all ECM constitutions.Entities:
Keywords: Korean medicine; eight constitution medicine (ECM); genome-wide association study (GWAS); phylogenetic analysis; single nucleotide polymorphism (SNP)
Mesh:
Year: 2022 PMID: 36065883 PMCID: PMC9446411 DOI: 10.14814/phy2.15459
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
FIGURE 1Eight pulse patterns of the radial artery in eight constitutional medicine (a) ECM pulse diagnosis is different from the traditional Korean pulse diagnosis, in terms of the location at which it is performed and the method that is used. The diagnostic procedure is as follows: First, the physician asks the patient to lie down and grips the patient's LEFT wrist (LEFT) with the doctor's right three fingers contacting the patient's radial artery. The position of the physician's index finger (1), middle finger (2) and ring finger (3) is placed on the radial artery line that is 5cm below the patient’ s radial styloid process. Next, the physician presses the patient's radial artery until the pulse can no longer be felt. Then, the physician releases the pressure of three fingers applied to the artery and catches where the first strongest pulse bounces up. The same process is also performed on the patient's right wrist with the physician's left hand (RIGHT). The physician should take into consideration the inclination of the patient's radius and give the three fingers the same strength to press the patient's wrist evenly. (b) The diagnosis of eight constitutions were made using unique pulse patterns composed of the combination of pulse formations on both the left and right radial arteries. The curved line in the present figure indicates the first pulse wave increase; the box indicates the pulse strength.
FIGURE 2The schematic flowchart of SNP selection for Korean ECM (32 HEP group and 31 PUL group)
FIGURE 3Manhattan plot of the GWAS results for ‘Hepatonia’ (HEP) and ‘Pulmotonia’ 2 (PUL) constitutions; − log10 (p‐value) of alleles for HEP against PUL were plotted against 3 chromosomal position. All the p‐values are over 5 × 10–5.
SNPs associated with ‘Hepatonia’ (HEP) and ‘Pulmotonia’ (PUL) constitutions at p < 1E‐03
| CHR | SNP | BP | A1 | A2 | MAF | OR | L95 | U95 | P | Feature | Gene |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11 | rs7946090 | 44,592,908 | A | G | 0.287 | 6.744 | 2.377 | 19.13 | 3.34.E‐04 | intron_variant | CD82 |
| 9 | rs10816235 | 9,920,242 | G | T | 0.2726 | 0.1481 | 0.05204 | 0.4214 | 3.45.E‐04 | intron_variant | PTPRD |
| 3 | rs13058921 | 54,137,943 | G | T | 0.244 | 0.1473 | 0.05099 | 0.4254 | 4.01.E‐04 | intron_variant | CACNA2D3 |
| 5 | rs248184 | 179,275,279 | C | A | 0.2323 | 0.1473 | 0.05099 | 0.4254 | 4.01.E‐04 | intron_variant | ADAMTS2 |
| 10 | rs4748151 | 15,279,060 | T | C | 0.3947 | 0.2487 | 0.1143 | 0.5411 | 4.50.E‐04 | intron_variant | FAM171A1 |
| 12 | rs2306393 | 68,314,981 | C | T | 0.4745 | 6.589 | 2.285 | 19 | 4.84.E‐04 | missense_variant | MDM1 |
| 3 | rs62269264 | 116,670,814 | A | G | 0.3869 | 5.72 | 2.143 | 15.26 | 4.97.E‐04 | intergenic_region | LSAMP‐TUSC7 |
| 5 | AX‐35245709 | 180,069,422 | T | C | 9.318 | 2.648 | 32.79 | 5.07.E‐04 | intron_variant | RNF130 | |
| 4 | rs2102702 | 17,024,068 | A | C | 0.2787 | 0.131 | 0.04161 | 0.4125 | 5.15.E‐04 | intergenic_region | LDB2‐LOC101929123 |
| 4 | rs1514983 | 17,024,831 | A | G | 0.2732 | 0.131 | 0.04161 | 0.4125 | 5.15.E‐04 | intergenic_region | LDB2‐LOC101929123 |
| 3 | AX‐247301836 | 116,710,060 | A | C | 0.2158 | 0.09029 | 0.5159 | 5.64.E‐04 | intron_variant | TUSC7 | |
| 13 | rs7326543 | 61,402,698 | G | A | 0.392 | 5.592 | 2.09 | 14.96 | 6.08.E‐04 | intergenic_region | MIR3169‐PCDH20 |
| 12 | rs2870812 | 68,325,436 | G | A | 0.4721 | 6.33 | 2.192 | 18.28 | 6.49.E‐04 | splice_region_variant | MDM1 |
| 12 | rs962976 | 68,326,847 | G | A | 0.4722 | 6.287 | 2.181 | 18.12 | 6.64.E‐04 | missense_variant | MDM1 |
| 3 | rs10934365 | 116,725,899 | T | C | 0.3192 | 0.2191 | 0.0907 | 0.5295 | 7.45.E‐04 | intergenic_region | TUSC7‐MIR4447 |
| 3 | rs1432364 | 116,726,477 | T | G | 0.3191 | 0.2191 | 0.0907 | 0.5295 | 7.45.E‐04 | intergenic_region | TUSC7‐MIR4447 |
| 4 | rs12508896 | 10,544,229 | G | A | 0.4448 | 0.25 | 0.1116 | 0.5603 | 7.60.E‐04 | intron_variant | CLNK |
| 8 | rs1154099 | 4,503,122 | G | A | 0.25 | 0.1116 | 0.5603 | 7.60.E‐04 | intron_variant | CSMD1 | |
| 12 | rs1602185 | 25,421,712 | A | G | 0.2646 | 0.1694 | 0.0601 | 0.4776 | 7.87.E‐04 | intergenic_region | KRAS‐LMNTD1 |
| 7 | rs2539967 | 20,937,592 | C | T | 0.4525 | 0.2138 | 0.08667 | 0.5276 | 8.15.E‐04 | intron_variant | LINC01162 |
| 5 | rs1864975 | 167,460,624 | C | T | 0.2625 | 0.1668 | 0.0582 | 0.4778 | 8.53.E‐04 | intron_variant | TENM2 |
| 5 | rs329120 | 134,526,066 | T | C | 0.4109 | 5.52 | 2.02 | 15.08 | 8.64.E‐04 | upstream_gene_variant | JADE2 |
| 10 | rs1649081 | 58,532,684 | G | G | 0.4966 | 3.821 | 1.735 | 8.416 | 8.78.E‐04 | intron_variant | BICC1 |
| 6 | rs901363 | 158,757,313 | C | T | 0.1853 | 8.5 | 2.401 | 30.09 | 9.06.E‐04 | missense_variant | SYTL3 |
| 8 | rs9886648 | 139,861,686 | T | C | 0.2286 | 0.164 | 0.05633 | 0.4773 | 9.11.E‐04 | intron_variant | TRAPPC9 |
| 4 | rs17087289 | 56,955,516 | C | T | 0.2593 | 0.1556 | 0.05179 | 0.4672 | 9.13.E‐04 | intergenic_region | REST‐NOA1 |
| 3 | rs1540734 | 135,557,947 | A | C | 0.4446 | 4.776 | 1.894 | 12.04 | 9.23.E‐04 | intergenic_region | EPHB1‐PPP2R3A |
| 6 | rs28499100 | 167,477,040 | A | G | 0.2491 | 6.077 | 2.089 | 17.68 | 9.28.E‐04 | upstream_gene_variant | LOC105378127 |
| 4 | AX‐41378891 | 146,617,731 | A | G | 5.133 | 1.949 | 13.52 | 9.29.E‐04 | intergenic_region | RNU1‐44P‐POU4F2 | |
| 9 | rs963469 | 76,112,335 | A | C | 0.4351 | 0.2742 | 0.1274 | 0.5901 | 9.37.E‐04 | intron_variant | PCSK5 |
| 13 | rs1412951 | 103,588,302 | G | A | 0.43 | 0.2083 | 0.08199 | 0.5294 | 9.79.E‐04 | intergenic_region | LINC01309‐DAOA‐AS1 |
| 10 | rs11012537 | 21,126,655 | G | A | 0.228 | 0.1949 | 0.07371 | 0.5154 | 9.81.E‐04 | intron_variant | C10orf113 |
Abbreviations: A1, Minor frequency allele; A2, Major frequency allele; BP, Base‐pair position; CHR, Chromosome; L95, Lower 95% confidence interval; OR, Odds ratio; P, unadjusted p‐value; SNP, single nucleotide polymorphism; U95, Upper 95% confidence interval.
The odds ratio (OR) > 1.0 indicates the individuals with minor frequency allele (A1) would be more likely to be classified under the PUL constitution than those with major frequency allele homozygotes.
GWAS results associated with the liver
| CHR | SNP | BP | A1 | OR | L95 | U95 | P | Trait |
|---|---|---|---|---|---|---|---|---|
| 1 | rs2499604 | 237,940,201 | C | 0.2654 | 0.1151 | 0.6119 | 1.85E‐03 | Non‐alcoholic fatty liver disease histology(AST) |
| 4 | rs222054 | 71,738,582 | G | 0.2437 | 0.08958 | 0.6628 | 5.68E‐03 | Non‐alcoholic fatty liver disease histology(other) |
| 1 | rs12743824 | 99,317,401 | C | 0.3868 | 0.1731 | 0.8643 | 2.06E‐02 | Non‐alcoholic fatty liver disease histology(other) |
| 1 | rs4949718 | 76,433,779 | T | 0.3715 | 0.1542 | 0.8952 | 2.73E‐02 | Liver enzyme levels (aspartate transaminase) |
| 5 | rs251891 | 115,714,665 | T | 2.385 | 1.075 | 5.291 | 3.24E‐02 | Liver injury in combined anti‐retroviraland |
| 1 | rs12145922 | 88,680,551 | A | 2.666 | 1.042 | 6.821 | 4.08E‐02 | Liver enzyme levels (gamma‐glutamyl transferase) |
| 8 | rs7820212 | 52,506,268 | T | 0.1048 | 0.01201 | 0.9142 | 4.12E‐02 | Immunoglobulin light chain (AL) amyloidosis(liver) |
| 2 | rs13030978 | 191,252,512 | T | 2.225 | 1.003 | 4.938 | 4.92E‐02 | Liver enzyme levels (gamma‐glutamyl transferase) |
Abbreviations: A1, Minor frequency allele; BP, Base‐pair position; CHR, Chromosome; L95, Lower 95% confidence interval; OR, Odds ratio; P, unadjusted p‐value; SNP, single nucleotide polymorphism; U95, Upper 95% confidence interval.
The odds ratio >1.0 indicates the individuals with minor frequency allele (A1) would be more likely to PUL constitution than those with major frequency allele homozygotes.
GWAS results associated with the lung
| CHR | SNP | BP | A1 | OR | L95 | U95 | P | Trait |
|---|---|---|---|---|---|---|---|---|
| 1 | rs10436951 | 243,199,378 | G | 0.2135 | 0.07486 | 0.609 | 3.89E‐03 | Lung cancer in ever smokers |
| 1 | rs3009947 | 218,515,813 | C | 0.3052 | 0.1153 | 0.8082 | 1.69E‐02 | Lung function (FEV1/FVC) |
| 6 | rs12201912 | 116,908,643 | A | 0.3374 | 0.1352 | 0.8421 | 1.99E‐02 | Lung function (FEV1/FVC) |
| 12 | rs2348418 | 28,536,581 | C | 2.459 | 1.119 | 5.405 | 2.52E‐02 | Lung function (FVC) |
| 3 | rs764129 | 185,830,129 | T | 2.237 | 1.071 | 4.673 | 3.22E‐02 | Lung function (FEV1/FVC) |
| 10 | rs2637254 | 76,552,244 | A | 2.497 | 1.08 | 5.772 | 3.23E‐02 | Lung function (FVC) |
| 8 | rs2608029 | 128,157,880 | C | 4.422 | 1.129 | 17.32 | 3.28E‐02 | Lung adenocarcinoma |
| 11 | rs546131 | 34,830,213 | G | 0.3422 | 0.1269 | 0.9228 | 3.41E‐02 | Lung disease severity in cystic fibrosis |
| 10 | rs10824305 | 75,380,711 | C | 2.492 | 1.063 | 5.844 | 3.57E‐02 | Lung function (FEV1/FVC) |
| 2 | rs2571445 | 217,818,431 | A | 0.4545 | 0.2152 | 0.9599 | 3.87E‐02 | Lung function (FVC) |
| 11 | rs541601 | 126,139,605 | T | 0.4544 | 0.2092 | 0.9868 | 4.62E‐02 | Lung function (FEV1/FVC) |
| 8 | rs10113175 | 127,057,790 | C | 0.288 | 0.08398 | 0.9876 | 4.77E‐02 | Lung cancer in never smokers |
| 9 | rs9299346 | 101,611,505 | A | 0.4361 | 0.1908 | 0.9966 | 4.91E‐02 | Methotrexate‐induced interstitial lung disease in rheumatoid arthritis |
| 10 | rs2579762 | 76,559,121 | C | 2.348 | 1.001 | 5.507 | 4.98E‐02 | Lung function (FEV1/FVC) |
| 1 | rs755249 | 39,529,402 | T | 0.2444 | 0.05982 | 0.9989 | 4.98E‐02 | Lung function (FEV1/FVC) |
Abbreviations: A1, Minor frequency allele, BP, Base‐pair position; CHR, Chromosome; L95, Lower 95% confidence interval; OR, Odds ratio; SNP, single nucleotide polymorphism; U95, Upper 95% confidence interval; P, unadjusted p‐value.
The odds ratio >1.0 indicates the individuals with minor frequency allele (A1) would be more likely to PUL constitution than those with major frequency allele homozygotes.
FIGURE 4Constitutional phylogenetic trees showing HEP and PUL (a) maximum likelihood tree (bootstrap 100) was constructed by the SNPhylo using all the genome‐wide SNPs with GWAS p‐value <0.05. The seven clusters in the tree did not show a distinct difference between HEP and PUL constitutions. (b) the same genome‐wide phylogenetic analysis was conducted by the SNPhylo using 8 SNPs related to the liver phenotype, 15 SNPs related to the lung phenotype selected from GWAS results on HEP and PUL subjects and 287 SNPs with GWAS p‐value <5 × 10–3. This lung and liver phenotype‐related SNP phylogenetic tree showed two clusters reflecting a distinct difference between HEP and PUL. HEP, Hepatonia; PUL, Pulmotonia.